将临床药剂师纳入护理过渡:联邦合格医疗中心的障碍与促进因素定性研究

IF 1.3 Q4 PHARMACOLOGY & PHARMACY
Ben C. D. Weideman M.S., Katie M. White EdD, MBA, Joel F. Farley Ph.D., Lindsay A. Sorge Pharm.D., MPH, Swetha Pradeep Pharm.D., Athena Cannon Pharm.D., Kim Tran Pharm.D., Deborah L. Pestka Pharm.D., Ph.D.
{"title":"将临床药剂师纳入护理过渡:联邦合格医疗中心的障碍与促进因素定性研究","authors":"Ben C. D. Weideman M.S.,&nbsp;Katie M. White EdD, MBA,&nbsp;Joel F. Farley Ph.D.,&nbsp;Lindsay A. Sorge Pharm.D., MPH,&nbsp;Swetha Pradeep Pharm.D.,&nbsp;Athena Cannon Pharm.D.,&nbsp;Kim Tran Pharm.D.,&nbsp;Deborah L. Pestka Pharm.D., Ph.D.","doi":"10.1002/jac5.1927","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Comprehensive medication management (CMM) is a service provided by clinical pharmacists. CMM aims to optimize pharmacotherapy outcomes by ensuring patients' medications are indicated, effective, safe, and patients are able to adhere to the prescribed medication regimen and take the medications as intended. The goal of CMM is to optimize patients' medications to ensure they are meeting their medication and health-related goals.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>The objective of this project is to evaluate facilitators and barriers to integrating CMM during transitions of care (ToC) at Federally Qualified Health Centers (FQHCs).</p>\n </section>\n \n <section>\n \n <h3> Design</h3>\n \n <p>Semistructured qualitative interviews were conducted with 22 key informants identified through purposive sampling at three FQHCs. Interviews were coded and analyzed deductively using a modified Consolidated Framework for Implementation Research (CFIR) adapted for ToC.</p>\n </section>\n \n <section>\n \n <h3> Key Results</h3>\n \n <p>Thirty-nine codes were identified across all CFIR constructs, including the addition of a new construct, “Patient characteristics.” Major facilitators included the perceived advantage and feasibility of the intervention, standardization of ToC processes, and organizational buy-in. Major barriers included health information technology system limitations, communication barriers with discharge facilities, technical and staffing challenges in applying criteria to identify patients for CMM, and low patient throughput.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Identifying early-stage barriers and facilitators are key to maximize facilitators and address barriers to support successful implementation. The findings of this work are being used to guide project adaptations to better integrate CMM into the ToC processes.</p>\n </section>\n </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.1927","citationCount":"0","resultStr":"{\"title\":\"Integrating clinical pharmacists into transitions of care: A qualitative study of barriers and facilitators among federally qualified health centers\",\"authors\":\"Ben C. D. Weideman M.S.,&nbsp;Katie M. White EdD, MBA,&nbsp;Joel F. Farley Ph.D.,&nbsp;Lindsay A. Sorge Pharm.D., MPH,&nbsp;Swetha Pradeep Pharm.D.,&nbsp;Athena Cannon Pharm.D.,&nbsp;Kim Tran Pharm.D.,&nbsp;Deborah L. Pestka Pharm.D., Ph.D.\",\"doi\":\"10.1002/jac5.1927\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Comprehensive medication management (CMM) is a service provided by clinical pharmacists. CMM aims to optimize pharmacotherapy outcomes by ensuring patients' medications are indicated, effective, safe, and patients are able to adhere to the prescribed medication regimen and take the medications as intended. The goal of CMM is to optimize patients' medications to ensure they are meeting their medication and health-related goals.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>The objective of this project is to evaluate facilitators and barriers to integrating CMM during transitions of care (ToC) at Federally Qualified Health Centers (FQHCs).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Design</h3>\\n \\n <p>Semistructured qualitative interviews were conducted with 22 key informants identified through purposive sampling at three FQHCs. Interviews were coded and analyzed deductively using a modified Consolidated Framework for Implementation Research (CFIR) adapted for ToC.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Key Results</h3>\\n \\n <p>Thirty-nine codes were identified across all CFIR constructs, including the addition of a new construct, “Patient characteristics.” Major facilitators included the perceived advantage and feasibility of the intervention, standardization of ToC processes, and organizational buy-in. Major barriers included health information technology system limitations, communication barriers with discharge facilities, technical and staffing challenges in applying criteria to identify patients for CMM, and low patient throughput.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Identifying early-stage barriers and facilitators are key to maximize facilitators and address barriers to support successful implementation. The findings of this work are being used to guide project adaptations to better integrate CMM into the ToC processes.</p>\\n </section>\\n </div>\",\"PeriodicalId\":73966,\"journal\":{\"name\":\"Journal of the American College of Clinical Pharmacy : JACCP\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.1927\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American College of Clinical Pharmacy : JACCP\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jac5.1927\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Clinical Pharmacy : JACCP","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jac5.1927","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

综合药物管理 (CMM) 是由临床药剂师提供的一项服务。CMM 旨在通过确保患者用药的适应症、有效性和安全性,并确保患者能够坚持按处方用药和按计划服药,从而优化药物治疗效果。本项目旨在评估在联邦合格医疗中心(FQHC)的护理过渡(ToC)过程中整合 CMM 的促进因素和障碍。我们在三家联邦合格医疗中心通过有目的的抽样确定了 22 位关键信息提供者,并对他们进行了半结构化定性访谈。访谈采用为 ToC 修改的实施研究综合框架(CFIR)进行编码和演绎分析。在所有 CFIR 结构中确定了 39 个编码,包括新增的 "患者特征 "结构。主要的促进因素包括干预措施的优势和可行性、ToC 流程的标准化以及组织的支持。主要障碍包括医疗信息技术系统的限制、与出院设施的沟通障碍、应用标准识别 CMM 患者的技术和人员挑战,以及患者吞吐量低。这项工作的结果将用于指导项目调整,以便更好地将 CMM 纳入 ToC 流程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Integrating clinical pharmacists into transitions of care: A qualitative study of barriers and facilitators among federally qualified health centers

Integrating clinical pharmacists into transitions of care: A qualitative study of barriers and facilitators among federally qualified health centers

Background

Comprehensive medication management (CMM) is a service provided by clinical pharmacists. CMM aims to optimize pharmacotherapy outcomes by ensuring patients' medications are indicated, effective, safe, and patients are able to adhere to the prescribed medication regimen and take the medications as intended. The goal of CMM is to optimize patients' medications to ensure they are meeting their medication and health-related goals.

Objective

The objective of this project is to evaluate facilitators and barriers to integrating CMM during transitions of care (ToC) at Federally Qualified Health Centers (FQHCs).

Design

Semistructured qualitative interviews were conducted with 22 key informants identified through purposive sampling at three FQHCs. Interviews were coded and analyzed deductively using a modified Consolidated Framework for Implementation Research (CFIR) adapted for ToC.

Key Results

Thirty-nine codes were identified across all CFIR constructs, including the addition of a new construct, “Patient characteristics.” Major facilitators included the perceived advantage and feasibility of the intervention, standardization of ToC processes, and organizational buy-in. Major barriers included health information technology system limitations, communication barriers with discharge facilities, technical and staffing challenges in applying criteria to identify patients for CMM, and low patient throughput.

Conclusions

Identifying early-stage barriers and facilitators are key to maximize facilitators and address barriers to support successful implementation. The findings of this work are being used to guide project adaptations to better integrate CMM into the ToC processes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信